ATE384078T1 - Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten - Google Patents

Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten

Info

Publication number
ATE384078T1
ATE384078T1 AT03775022T AT03775022T ATE384078T1 AT E384078 T1 ATE384078 T1 AT E384078T1 AT 03775022 T AT03775022 T AT 03775022T AT 03775022 T AT03775022 T AT 03775022T AT E384078 T1 ATE384078 T1 AT E384078T1
Authority
AT
Austria
Prior art keywords
shrew
therapy
neuromuscular diseases
paralytic
peptides
Prior art date
Application number
AT03775022T
Other languages
English (en)
Inventor
John M Stewart
Bradley J Steeves
Karl Vernes
Original Assignee
Bioprospecting Nb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprospecting Nb Inc filed Critical Bioprospecting Nb Inc
Application granted granted Critical
Publication of ATE384078T1 publication Critical patent/ATE384078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03775022T 2002-11-18 2003-11-18 Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten ATE384078T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42768202P 2002-11-18 2002-11-18

Publications (1)

Publication Number Publication Date
ATE384078T1 true ATE384078T1 (de) 2008-02-15

Family

ID=32326580

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03775022T ATE384078T1 (de) 2002-11-18 2003-11-18 Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten

Country Status (8)

Country Link
US (1) US7485622B2 (de)
EP (1) EP1601691B1 (de)
AT (1) ATE384078T1 (de)
AU (1) AU2003283160A1 (de)
CA (1) CA2544467C (de)
DE (1) DE60318749T2 (de)
ES (1) ES2300625T3 (de)
WO (1) WO2004046178A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2262567T3 (es) 2001-03-20 2006-12-01 Schwarz Pharma Ag Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico.
DK1243263T3 (da) 2001-03-21 2003-03-17 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte
US7119168B2 (en) 2002-11-18 2006-10-10 Bioprospecting Nb Inc. Paralytic peptide for use in neuromuscular therapy
US7427601B2 (en) 2004-06-24 2008-09-23 Schwarz Pharma Ag Method for treating tremor
EP1781276B1 (de) 2004-08-27 2010-06-23 UCB Pharma GmbH Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
AR061476A1 (es) 2006-06-15 2008-08-27 Sanol Arznei Schwarz Gmbh Composicion farmaceutica con efecto anticonvulsivo sinergico
JP5749154B2 (ja) 2008-03-19 2015-07-15 ソリシメド・バイオファーマ・インコーポレーテッド Ｔｒｐｖ６カルシウムチャネル活性阻害による癌治療のためのペプチド組成物
JP5836940B2 (ja) * 2009-06-26 2015-12-24 ソリシメド・バイオファーマ・インコーポレーテッド ソリシジン由来ペプチドならびにｔｒｐｖ−６がんの検出および薬剤送達のための方法
WO2014040178A1 (en) * 2012-09-14 2014-03-20 Stewart John M Trpv3 agonists for the treatment of skin conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
JPH10236963A (ja) 1997-02-26 1998-09-08 Sagami Chem Res Center カルシウムチャンネル拮抗剤
AU7389098A (en) * 1997-05-16 1998-12-08 Brigham And Women's Hospital Local anesthetic formulations

Also Published As

Publication number Publication date
US20060217302A1 (en) 2006-09-28
CA2544467C (en) 2014-02-18
AU2003283160A8 (en) 2004-06-15
CA2544467A1 (en) 2004-06-03
DE60318749T2 (de) 2009-01-22
WO2004046178A3 (en) 2004-07-22
AU2003283160A1 (en) 2004-06-15
US7485622B2 (en) 2009-02-03
WO2004046178A2 (en) 2004-06-03
EP1601691A2 (de) 2005-12-07
ES2300625T3 (es) 2008-06-16
EP1601691B1 (de) 2008-01-16
DE60318749D1 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20030895L (no) Ny anvendelse av dipeptidyl peptidase IV inhibitorer
ATE549028T1 (de) Stabile analoga von glp-1
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
DE69533264D1 (de) Inhibitoren der il-6 aktivitaet
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
EA200401471A1 (ru) Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов
CY1108146T1 (el) ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ
BG101841A (en) Cellular adhesion inhibitors
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
TR199802537T2 (xx) Peptit t�revleri.
EA200500244A1 (ru) Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
ATE384078T1 (de) Paralytisches peptide von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten
AP1795A (en) Peptide deformylase inhibitors.
DE60303312D1 (de) Thrombinspaltbare faktor-x-analoga
BR0312889A (pt) Polipeptìdeo t20 peguilado
ATE251614T1 (de) Piperazinderivate als neurokinin-antagonisten
DE69629023D1 (de) Piperazino-derivative als neurokininantagonisten
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
DE69535460D1 (de) Pharmazeutische peptide formulierungen zur behandlung von staubmilben allergie
NO991653D0 (no) Immunogenisk tumor frigjorte partikler (TLP)-blanding

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties